Correlation Between Apogee Therapeutics, and Ameriprise Financial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Ameriprise Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Ameriprise Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Ameriprise Financial, you can compare the effects of market volatilities on Apogee Therapeutics, and Ameriprise Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Ameriprise Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Ameriprise Financial.

Diversification Opportunities for Apogee Therapeutics, and Ameriprise Financial

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Apogee and Ameriprise is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Ameriprise Financial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ameriprise Financial and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Ameriprise Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ameriprise Financial has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Ameriprise Financial go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Ameriprise Financial

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Ameriprise Financial. In addition to that, Apogee Therapeutics, is 1.62 times more volatile than Ameriprise Financial. It trades about -0.18 of its total potential returns per unit of risk. Ameriprise Financial is currently generating about 0.24 per unit of volatility. If you would invest  50,274  in Ameriprise Financial on August 25, 2024 and sell it today you would earn a total of  6,933  from holding Ameriprise Financial or generate 13.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Ameriprise Financial

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Ameriprise Financial 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ameriprise Financial are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak primary indicators, Ameriprise Financial reported solid returns over the last few months and may actually be approaching a breakup point.

Apogee Therapeutics, and Ameriprise Financial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Ameriprise Financial

The main advantage of trading using opposite Apogee Therapeutics, and Ameriprise Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Ameriprise Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ameriprise Financial will offset losses from the drop in Ameriprise Financial's long position.
The idea behind Apogee Therapeutics, Common and Ameriprise Financial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum